2008 BIO International Convention Focuses on Global Reach of Biotechnology.Wednesday, June 18(th) Designated as BIO International Day WASHINGTON -- The 2008 BIO International Convention will demonstrate the biotechnology industry's global focus with international case studies, global health breakout sessions and receptions that spotlight examples of biotechnology innovation from around the world. The BIO International Convention, hosted by the Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links
"The 2008 BIO International Convention truly is the global event for biotechnology with industry leaders coming from around the world to share their unique perspectives and experiences and connect with others," said Robbi Lycett, BIO vice president, conventions and conferences. Since 2006, the international attendance has grown by more than 24% and now makes up more than 30% of the audience. The 2007 BIO International Convention in Boston saw double-digit percentage growth from Spain, Malaysia, Canada, German, India, and the United Kingdom. In 2008, more growth is expected from Asia and Latin America Latin America, the Spanish-speaking, Portuguese-speaking, and French-speaking countries (except Canada) of North America, South America, Central America, and the West Indies. . The convention has seen a significant increase in attendance of international public officials from 45 in 2005 up to 72 during the Boston event. Notable leaders in attendance have included the Deputy Prime Minister of Malaysia Deputy Prime Minister of Malaysia (Timbalan Perdana Menteri in Malay) is the second highest political post in Malaysia. Malaysia has so far nine persons appointed to the post. , the Deputy Director General of the China State Food and Drug Administration The State Food and Drug Administration (SFDA Simplified Chinese: 国家食品药品监督管理局) is founded on the basis of the State Drug Administration. , India's Director of the Department for Biotechnology, and South Africa's Minister of Agriculture. Sean Darragh, BIO executive vice president, international affairs Noun 1. international affairs - affairs between nations; "you can't really keep up with world affairs by watching television" world affairs affairs - transactions of professional or public interest; "news of current affairs"; "great affairs of state" , added that "The spike in attendance of public officials from around the globe to the BIO International Convention in recent years reflects a growing recognition that the BIO International Convention offers thought leaders a unique venue to interact, collaborate and exchange ideas." Global health breakout sessions will highlight numerous issues, including research and development, partnership opportunities, and the new business models required to meet global health challenges. Sessions include: * International Networking of R&D for Neglected Diseases The Neglected Diseases are a group of tropical infections which are especially endemic in low-income populations in developing regions of Africa, Asia, and the Americas. Different groups define the set of diseases differently. * How Can Industry Collaborate with Public Health Organizations in Emerging Markets? * Innovative Business Models to Balance Developed World Revenues with Developing World Access * New Partnership Models in Advancing HIV Vaccine HIV vaccine AIDS As of mid-2005, there is no viable anti-HIV vaccine. See AIDS. Development International case studies on biofuels, biomanufacturing, research funding Research funding is a term generally covering any funding for scientific research, in the areas of both "hard" science and technology and social science. The term often connotes funding obtained through a competitive process, in which potential research projects are evaluated and , and international collaborations will focus on examples from Brazil, China, France, Germany, India, Japan, Korea, North Korea, North officially Democratic People's Republic of Korea Country, East Asia, occupying the northern half of the Korean peninsula. Area: 47,399 sq mi (122,762 sq km). Population (2005 est.): 22,488,000. Capital: P'yongyang. America, Singapore, and Sweden. A sample of sessions includes: * Biotechnology and Life Sciences in the EU: Current Developments in Regulations, IPR IPR Intellectual Property Rights IPR Inprocess/Inprogress Review IPR Industrial Property Rights IPR Institute for Policy Research (Northwestern University and University of Cincinnati) IPR Institute of Public Relations and Research Funding * Biotechnology and Sustainable Energy
Sustainable energy sources are energy sources which are not expected to be depleted in a timeframe relevant to the human race, and which Production: EU-U.S. Cooperation in Research * International collaboration through EU research programs, with case studies from North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. and the Pacific Region A special super session, "The Dynamics of a Globalized World and the Future of the Biotechnology Industry," moderated by Dr. Moira Gunn, host of National Public Radio's Biotech Nation, along with panelists James C. Mullen, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Biogen Idec Biogen Idec, Inc. (NASDAQ: BIIB) is a biotechnology company specializing in drugs for neurological disorders, autoimmune disorders and cancer. The company was formed in 2003 by the merger of Cambridge, Massachusetts-based Biogen and San Diego, California-based Idec , Inc.; Kapil Sibal Kapil Sibal was born in Jalandhar, Punjab on August 8 1948. He obtained his M.A. in History from St. Stephen's College, University of Delhi, Delhi and LL.M. from Harvard Law School, USA. He was offered appointment to the Indian Administrative Service, but declined the offer. , Minister of Science and Technology, India; and Jose Lino Salvador Baranao, Minister of Science, Technology and Productive Innovation, Argentina will offer an industry perspective on evolving business models, country-by-country policy making and global economic dynamics. In addition, an International Biotechnology Marketplace and Reception will be held on Wednesday, June 18, as part of BIO International Day. The event will highlight the global issue of how to fuel the world efficiently and effectively. This table-top display networking event will spotlight the next generation of innovative biotechnology with a focus on biofuels. The International Biotechnology Marketplace will facilitate connections for governments, companies, and organizations from around the world to explore and discuss potential solutions to energy and environmental challenges. Attendees will have the chance to engage the participating organizations and examine a wide range of issues surrounding technology development and production, regional legislation and supporting infrastructure and environmental impact. The Marketplace will stimulate discussions of the various technical, social, economic and policy scenarios for the next generation of biofuels. For more information on the International Biotechnology Marketplace, please visit www.bio2008.org/international. The BIO International convention will highlight how biotechnology, the life sciences, investments, policy, and the international community work together to heal, fuel, and feed the world. This year, the day pattern will change to Tuesday through Friday (previously, the convention was held Sunday through Wednesday). The convention features more than 200,000 square feet of exhibitions showcasing the latest advancements in biotechnology alongside an array of potential partners, service providers, and state and international delegations. The 2008 convention also will include more than 175 breakout sessions, keynotes from global leaders, business partnering meetings, and several networking events. BIO anticipates more than 20,000 industry leaders, government officials, and others will attend the 2008 International Convention. The convention was last held in San Diego in 2001 and attracted 14,731 professionals. In 2007, the convention attracted 22,366 attendees and exhibitors with approximately one-third from countries outside the U.S. The 2007 event also hosted more than 300 domestic and international public officials including seven U.S. governors. Registration is complimentary for credentialed members of the news media. To register, please visit www.bio2008.org/mediaregistration. Reporters and editors working full-time for print, broadcast, and online news organizations may register onsite with valid media credentials. All freelancers, college and online publications are strongly encouraged to register in advance by Wednesday, June 4, 2008. Registration for attendees is offered at an early-bird discounted rate until May 8, 2008. Online registration is available at www.bio2008.org/registration. The BIO International Convention helps to support the association's programs and initiatives. BIO works throughout the year to create a policy environment that enables the industry to continue to fulfill its vision of bettering the world through biotechnology innovation. For more information on the global event for biotechnology, including program, registration, and housing information, please visit www.bio2008.org. About BIO BIO represents more than 1,200 biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. , academic institutions, state biotechnology centers and related organizations across the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. BIO also produces the annual BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. Upcoming BIO Events
-- <
BIO-Europe Spring
<
April 7-9, 2008
<
Madrid, Spain
<
-- <
BIO National Venture Conference
<
April 22-23, 2008
<
Boston, Mass.
<
-- <
World Congress on Industrial Biotechnology & Bioprocessing
<
April 27-30, 2008
<
Chicago, Ill.
<
-- <
2008 BIO International Convention
<
June 17-20, 2008
<
San Diego, Calif.
|
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion